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Abstract
Purpose To establish the age- and sex-specific
prevalence of open-angle glaucoma (OAG)
subsuming pseudoexfoliation (PEX) in the city
of Reykjavik.
Methods Participants 50 years of age
and older who were part of the Reykjavik
Eye Study and classified as having glaucoma
were divided into three categories:
Category 1: two or more of the following based
on optic nerve stereophotograph reading:
vertical cup to disc ratio (VCDR) 97.5th
percentile (40.7), focal glaucomatous disc
change, C/D asymmetry of 97.5th percentile
difference between eyes (40.2) as well as
glaucomatous visual field defect (GVFD).
Category 2: 99.5th percentile of VCDR (40.8)
and 99.5% percentile difference between eyes
(Z0.3), without a GVFD.
Category 3: VAo3/60 and IOP499.5th
percentile or VAo3/60 and evidence of
filtering surgery. For a glaucoma suspect,
one of the following was present:
VCDR499.5th percentile (40.8), focal
glaucomatous disc change, C/D asymmetry of
99.5th percentile (Z0.3), GVFD only,
IOPZ23 mmHg (97.5 percentile). PEX was
diagnosed by the presence of a central shield
and/or a peripheral band on the anterior lens
capsule.
Results Of 42 persons (22 males and 20
females) with OAG, 13 (31.0%) had PEX. The
minimum prevalence of OAG was 4.0%
(42/1045) (95% CI 2.8–5.2) for those 50 years
and older and 10.3% (95% CI 8.5–12.2) for PEX.
The prevalence of OAG increases with age
(OR¼ 1.10/year, 95% CI 1.07–1.13, P¼ 0.000)
and the same applies for the prevalence of
PEX, OR¼ 1.10 (95% CI 1.07–1.12, P¼ 0.000).
Conclusion There is a 10% annual increase
for both OAG and PEX in persons 50 years and
older.
Eye (2003) 17, 747–753. doi:10.1038/
sj.eye.6700374
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Introduction
The Icelandic population is almost exclusively
Caucasian, predominantly descendants of
settlers who arrived from Scandinavia and the
British Isles about 1100 years ago. During the
20th century, several glaucoma surveys have
been conducted in Iceland.1–5 Glaucoma was
found to be the commonest cause of blindness,
amounting to over 50% of all cases of blindness
in 1950.5 Surveys in the 1980s indicated that
glaucoma might be the second most common
cause of legal blindness in Iceland2–4
responsible for approximately 18% of blindness,
and in 1998 this figure was down to 8%.6
The purpose of the present study is to
establish the age- and sex-specific prevalence of
open-angle glaucoma (OAG), subsuming
pseudoexfoliative glaucoma in the city of
Reykjavik. This study is part of the Reykjavik
Eye Study7–10 that addressed the same questions
for age-related lens opacification and age-
related maculopathy.
Materials and methods
Following the guidelines of the Helsinki
Declaration, appropriate ethical approvals were
obtained from the Data Protection Commission
and the Hospital Ethics Committee.
The participants were citizens of Reykjavik 50
years and older, and were randomly sampled
using the National population census. A total of
6.4% people were sampled for each year of birth
and both sexes.7–10 Of those 1700 thus sampled,
1379 (81.1%) could be contacted and qualified of
which 1045 (461 male and 584 females) elected
to participate, giving a response rate of 75.8%.8
All were Caucasians. They were required to
answer a questionnaire regarding lifestyle,
health, previous disease, surgery, and
medication.7–10
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Examination
The site of the study was the University Eye Department
in Reykjavik. All participants were examined utilizing
a standard examination protocol including
keratorefractometry (Nidek ARK 900), air puff tonometry
(Nidek NT 2000, mean of three successful
measurements),10 Scheimpflug photography of the
anterior segment (Nidek EAS 1000),7 slit-lamp
examination of the anterior segment, biomicroscopy of
fundi with a 78D lens, and simultaneous stereo fundus
photography centred on the optic disc and another on the
fovea (Nidek 3Dx/NM). On the day of survey,
gonioscopy was not done since this would have
interfered with Scheimpflug and fundus photography.
After maximal dilation of pupils, with Tropicamide 1%
and Phenylephrine 10% eye drops, lenses were examined
for pseudoexfoliation (PEX) on the slit lamp by two
experienced examiners. Only those eyes with a central
shield and/or a peripheral band on the anterior lens
capsule were considered to have definite PEX, and if they
also had OAG they were considered to have
pseudoexfoliative glaucoma.
A subgroup of 85 people (8.1%) were recalled
approximately 3 and 12 months later for full-threshold
visual field assessment (octopus G1X) and gonioscopy
(Goldmann single mirror lens at 3 months). This
subgroup included all 45 people with a history of
glaucoma (one each with angle closure and neovascular
glaucoma and 43 with OAG) as well as 40 others
considered to have the appearance of the optic disc
suspect for glaucoma. The visual fields were evaluated in
a masked fashion, by two glaucoma specialists (FJ/ThS).
If the evaluation differed, the visual field was repeated
and the two specialists were then required to reach a
consensus. Grading of the optic discs was done by an
experienced glaucoma specialist (KFD), in a masked
fashion, using the simultaneous stereophotographs
centred on the horizontal disc and vertical disc, and cup
diameters were determined following the Beaver Dam
Eye Study protocol.11,12 A plastic template with small
circles ranging from 1/32 (0.031) to 1 14 (1.250) inches in
diameter in 1/64 (0.015) to 1/32 (0.031) inch increments
was used (Pickett, small circles no. 1203I) to grade disc
and cup diameters from photographs. This was done by
superimposing the circles over discs and cups measuring
the largest cup to disc ratio within 201 of the horizontal
and vertical midline. The quality of photographs was
assessed from 1 to 7 (1 and 2 represented categories that
were too poor for assessment, and 3–7 represented
varying degrees of improvement in quality). Of the 1045
people, 1026 had gradable stereophotographs for at least
one eye, 1015 had gradable photographs for the right eye
and 1014 for the left eye. Mean vertical cup to disc ratio
(VCDR) in our population is 0.4, SD 0.23, mode 0.5, range
0.0–1.0.
Definitions
Definitions for OAG, category 1–3, and the glaucoma
suspect are provided in Table 1. Where visual fields were
available, we utilized them in assigning diagnostic
status. Those who were found not to have glaucoma or
other conditions possibly affecting their optic nerve head
were used in our survey to establish the 97.5th and 99.5th
percentiles. Selection of VCDR 40.7 and 40.8 was based
on the 97.5th and 99.5th percentiles, respectively. This is
in keeping with suggestions made recently in the
literature by Wolfs et al13 and Foster et al14 for the
diagnosis of glaucoma in cross-sectional prevalence
surveys. Also included are C/D asymmetry of the 97.5th
percentile (40.2) and the 99.5th percentile (Z0.3) and
focal glaucomatous disc changes. The lower numbers are
criteria for category 1 and the higher numbers for
category 2 (Table 1).
In healthy eyes the 97.5% percentile cutoff for
intraocular pressure (IOP) was about 23 mmHg. Hence
an IOPZ23 mmHg was considered abnormal and
utilized as part of our definition of glaucoma suspect
(GS). Eyes where IOP had been affected by medication,
laser, or surgery were disregarded for this purpose.
The two eyes of a person are not independent
regarding IOP and C/D, and for statistical purposes we
therefore treated the right and left eyes separately in this
article. When considering those with PEX, only those
where the diagnosis was absolutely certain were
accepted, namely where a central shield and/or a
peripheral band were clearly seen. If there was any
uncertainty, the eyes were listed as PEX suspects.
For statistical analysis we used multiple logistic
regression, using the statistical package STATA (STATA
Corp., 1997).
Results
Of the 1700 people in the random sample, 65 had died
and 256 could not be located at their addresses indicated
in the population census, apparently since they had
moved without yet informing the Census Bureau. The
remaining 1379 people could be located whereof 1045
elected to participate in all examinations and answer a
questionnaire, giving a response rate of 75.8%. Those
unwilling to participate all answered a short
questionnaire on the phone, among other things giving
their reasons for non-participation.7
Table 2 shows the number, age and sex of the
participants as well as age- and sex-specific minimum
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per cent prevalence and confidence intervals of glaucoma
according to the definition outlined in Table 1.
The distribution of VCDR can be seen in Figure 1.
Besides normal variation, causes for optic neuropathy
other than glaucoma found were past history of temporal
arteritis, cerebrovascular accident, macular degeneration,
and Lebers optic atrophy. These last were excluded when
establishing disc criteria for glaucoma diagnosis.
Table 1 Classification criteria used for open-angle glaucoma and glaucoma suspect
Diagnostic criteria for open-angle glaucoma (modified from Foster et al14)
One of the following:
(1) Category 1 diagnosis (structural and functional evidence): 2/3 of the following criteria with a GVFD:
(a) Vertical cup to disc ratio Z97.5th percentile (>0.7)
(b) Focal glaucomatous disc change (disc haemorrhage, notch of the neuroretinal rim, marked sloping of rim tissue, narrowest
remaining rim of 0.1 disc diameter or less)
(c) C/D asymmetry Z97.5th percentile (>0.2)
(2) Category 2 diagnosis (structural evidence only with unproved field loss): 2/3 of the following criteria:
(a) Vertical cup to disc ratio Z99.5th percentile (>0.8)
(b) Focal glaucomatous disc change (disc haemorrhage, notch of the neuroretinal rim, marked sloping of rim tissue, narrowest
remaining rim of 0.1 disc diameter or less)
(c) C/D asymmetry Z99.5th percentile (Z0.3)
(3) Category 3 diagnosis (optic disc not seen, no field test): One of the following:
(a) VAo3/60 and IOP >99.5th percentile
(b) VAo3/60 and the eye shows evidence of glaucoma filtering surgery
Diagnostic criteria for open-angle glaucoma suspect
One of the following:
(1) IOPZ23 mmHg
(2) IOPZ23 mmHg with 1/3 of the following criteria for glaucomatous optic neuropathy (GON):
(a) Vertical cup to disc ratio Z99.5th percentile
(b) Focal glaucomatous disc change (disc haemorrhage, notch of the neuroretinal rim, marked sloping of rim tissue, narrowest
remaining rim of 0.1 disc diameter or less)
(c) C/D asymmetry Z99.5th percentile
(3) IOPZ23 mmHg with GVFD
(4) GVFD only
(5) 1/3 criterion for GON listed in (2) above
Criteria for GVFD included14
(a) Asymmetric across the horizontal midline (in early/moderate cases)
(b) Located in the mid-periphery (in early/moderate cases)
(c) Clustered in neighbouring test points
(d) Not explained by any other disease
(e) Considered a valid representation of the subject’s functional status (based on performance indices such as false positive rate)
Notes: In diagnosing category 1 or 2 glaucoma, alternative explanations for CDR findings or VF findings were excluded.
Exclusion criteria for OAG and for OAG suspects included other causes for glaucoma (eg uveitis, angle recession), corticosteroid use greater than
1 month (topical or systemic), iris abnormality other than peripupillary atrophy, past history of blunt or sharp trauma.
Table 2 Age- and sex-specific prevalence (%) of OAG and 95% confidence intervals
People examined People with OAG
Age (years) Males Females M+F M M% (95% CI) F F% (95% CI) M+F M+F% (95% CI)
50–59 167 195 362 2 1.2 (0.0–2.9) 0 0 2 0.6 (0.0–1.3)
60–69 144 210 354 4 2.8 (0.1–5.5) 6 2.9 (0.6–5.1) 10 2.8 (1.1–4.6)
70–79 116 135 251 10 8.6 (3.4–13.8) 10 7.4 (2.9–11.9) 20 8.0 (4.6–11.3)
80+ 34 44 78 6 17.6 (4.1–31.1) 4 9.1 (0.2–17.9) 10 12.8 (5.5–21.2)
461 584 1045 22 4.8 (2.8–6.7) 20 3.4 (1.9–4.9) 42 4.0 (2.8–5.2)
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We analysed IOP for healthy right eyes to establish
97.5% cutoff which was about 23 mmHg, and
IOPZ23 mmHg was used as a part of our definition of
glaucoma suspects. The results for the left eyes were
similar.10 The diagnosis of OAG in 42 people (Table 2)
was based on category 1 criteria in 17 people, including
2/3 disc criteria and glaucomatous visual field defect.
Seven (41.2%) of the last also had PEX. Twenty-five were
diagnosed on criteria for category 2, ie without visual
fields (19) or without visual field defect (6). No
participant was classified to belong to category 3, since
none had VAo3/60 related to OAG. Age- and sex-
specific prevalences for the 123 people considered to be
GSs according to the criteria outlined are shown in
Table 3. Two had IOPZ23 mmHg and 1/3 disc criteria, 13
had IOPZ23 mmHg only and 95 had disc criteria only.
One participant who had IOPs of 25 mmHg in the right
eye and 23 mmHg in the left eye was considered to have
glaucomatous optic neuropathy and was, on visual field
testing, found to have bitemporal visual field defect and,
on computerized tomography, to have pituitary tumour
that was removed surgically, uneventfully, within 1
month of the survey.
Forty-three people had a history of OAG and had
received pressure-lowering treatment, some possibly for
ocular hypertension. Seventeen of the 43 with a history of
glaucoma were identified among the 42 persons
diagnosed with glaucoma all in category 1 criteria, a
further 16 were considered GSs, and 10 participants
remained unidentified by our criteria and may have been
treated for ocular hypertension. Of the 42 people
diagnosed with glaucoma in our survey, 13 were
considered to have normal tension glaucoma (31.0%)
having IOPo21 mmHg without pressure-lowering
treatment.
On review of stereo optic nerve photographs, 10
females and two males had optic disc haemorrhage in
one eye, and were classified as OAG suspects. None of
these patients had other disc or visual field features to
suggest definitive OAG classification.
Definite PEX, ie characteristic fibrillar
pseudoexfoliative material visualized on the lens capsule
on slit-lamp examination after dilatation by both
examiners, was found in 145 eyes, 108 people, 93 female
and 52 male eyes. Of those 42 diagnosed by our
definition as having glaucoma, 13 (31.0%) had definite
PEX and a further seven (16.7%) were suspected of
having PEX. Thus, altogether 20 (47.6%) of the 42 people
with definite diagnosis of OAG had either definite PEX
or were suspected of having PEX. Regarding 123 GSs,
definite PEX was found in 23 people (18.4%), and in the
group (861) having neither glaucoma nor being GSs 8.4%
had PEX. Definite PEX in either eye greatly increased
with age from 2.5% of all people in the 50s to 33.3% in the
80s (Table 4). Multiple regression analysis shows that 1
year ageing increases the risk of developing PEX by 10%
(OR 1.10, 95% CI 1.07–1.12, P¼ 0.000). After correcting
for age, the OR for women as compared with men is 1.5%
(95% CI 1.0–2.3), Po0.06. Multiple regression analysis
also indicates a 10% increase per year for OAG (OR 1.10,
95% CI 1.07–1.13, P¼ 0.000). After correcting for age, PEX
is found to be a risk factor for being classified as a GS, OR
1.95 (CI 1.14–3.35), P¼ 0.015, while it is not a significant
risk factor for glaucoma according to our definition.
Discussion
We utilized data from the Reykjavik Eye Study to
examine the prevalence of OAG and PEX in Reykjavik,
Iceland. The response rate is considered acceptable
Table 3 Age- and sex-specific prevalence (%) of GSs (95% confidence intervals)
Age (years) M % (95% CI) F % (95% CI) M+F % (95% CI)
50–59 16 9.6 (5.1–14.1) 24 12.3 (7.7–17.0) 40 11.0 (7.8–14.3)
60–69 15 10.4 (5.4–15.5) 19 9.0 (5.1–13.0) 34 9.6 (6.5–12.7)
70–79 8 6.9 (2.2–11.6) 25 18.5 (11.9–25.2) 33 13.1 (8.9–17.4)
80+ 6 17.6 (4.1–31.1) 10 22.7 (9.8–35.6) 16 20.5 (11.3–29.7)
45 9.8 (7.0–12.5) 78 13.4 (10.6–16.1) 123 11.8 (9.8–13.7)
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Figure 1 Distribution of vertical cup to disc ratio, right eyes.
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(75.8%). Our study included institutionalized patients in
the oldest age group, which differs from some studies
that exclude this group.15 It was not possible to follow the
examination protocol outside the hospital, ie to do visual
field testing, fundus photography, and Scheimpflug
photography. The consequence is a considerable dropout
among those 80 years and older as a result of decreased
mobility.
For the definition of glaucoma, we decided to utilize a
structural criterion based on objective reading of
stereophotographs of the optic disc and, when available,
incorporate a functional definition to strengthen the
diagnostic classification. This approach and definition is
in keeping with recent studies,13,14 and suggestions of an
expert working group, for the diagnosis of glaucoma in
cross-sectional prevalence surveys.14 The fundamental
concept is that the term glaucoma is reserved for a
significant end organ damage. Our results for the 97.5th
(0.7) and 99.5th percentiles (0.8) are remarkably similar to
the results of previous studies.13,14 IOP is not a part of
this definition, although it is included as a criterion for
GSs. Of 43 people who had received treatment for
glaucoma prior to the survey, 17 were identified in the
present survey as having glaucoma, all in category 1. A
further 16 people were diagnosed as GSs and 10
remained unidentified and should probably be classified
as ocular hypertensives.
Normal tension glaucoma previously considered
uncommon in Iceland1–4 was found in 13 participants
(1.2%) and it constitutes 31.0% of OAG in this study. Two
of those had been on systemic and topical corticosteroid
treatment for some time in the past, which may have led
to temporary pressure rise and consequent glaucomatous
optic neuropathy. A third participant had cerebral basal
ganglia degeneration, motor and non-motor, and the
fourth had Bernard–Souliere syndrome, both conditions
possibly affecting the appearance of the optic disc and
visual fields. For the remainder, arterial hypertension
and treatment thereof were commonly found.
Comparing the present prevalence data with previous
Icelandic data,3 we find the prevalence of OAG similar
for those 50 to 69-year-olds, while the figures for those 70
years and older are somewhat lower in the present study.
This may be associated with different criteria since the
previous study used the Framingham Eye Study
criteria.16 Altogether 42 people are considered to have
OAG in our survey, a minimum per cent prevalence
of 4.0% for those 50 years and older. In Nottingham
in England, 1.3% of the population 50 years and older
were found to be on glaucoma medication and a further
1.4% were diagnosed as having OAG and put on
treatment.17 Another English survey18 found prevalence
in the age group 76–84 years to be 7.1%, compared with
9.8% (95% CI 4.9–14.7) in this study. Neither of the
English studies mentions PEX. In the Baltimore Eye
Study the prevalence of glaucoma is 1.3% for the white
population,19 and in Roscommon in Ireland 2%20 for
those 50 years and older. Since diagnostic criteria differ
somewhat between studies, direct comparison may be
fallacious.
We did not obtain a visual field on all participants and
this is a shortcoming of our study. However, in
epidemiological studies, visual fields may give relatively
high false positive and false negative results, particularly
in the older population.12,21 Thus in the Rotterdam Eye
Study, 18.4% of the participants failed the initial visual
field screening whereby 1.1% were eventually deemed to
have glaucoma on visual field criteria.21 Foster and co-
workers, considering visual field testing in prevalence
surveys, suggested that around 33% false negative
rate was not uncommonly found, with 95% CI 13 to
53%.14
We used a Nidek NT2000 non-contact airpuff
tonometer to measure IOP. This instrument has been
shown to give similar results to the Goldmann
applanation tonometer22 with slightly more variability.
We used the mean of three successful measurements,
outlying measurements being disregarded. Non-contact
tonometry has the benefit of avoiding anaesthesia and
the risk of infection and abrasion and does not interfere
with subsequent examination of the survey. Our IOP
results in healthy eyes are similar to those of many
previous studies,1,12,23–26 using Schio¨tz and applanation
tonometry.
There are arguments for and against including people
with glaucoma and PEX syndrome and pigment
dispersion syndrome as cases of OAG. We have included
them as a variant of OAG rather than classifying them as
Table 4 Age- and sex-specific prevalence (%) of pseudoexfoliation and 95% confidence intervals
Age (years) M % (95% CI) F % (95% CI) M+F % (95% CI)
50–59 2 1.2 (0.0–2.9) 7 3.6 (1.0–6.2) 9 2.5 (0.9–4.1)
60–69 12 8.3 (3.8–12.9) 19 9 (5.1–13.0) 31 8.8 (5.8–11.7)
70–79 15 12.9 (6.7–19.1) 27 20 (13.2–26.8) 42 16.7 (12.1–21.4)
80+ 10 29.4 (13.3–45.5) 16 36.3 (21.6–51.2) 26 33.3 (22.6–44.0)
39 8.5 (5.9–11.0) 69 11.8 (9.2–14.4) 108 10.3 (8.5–12.2)
Open-angle glaucoma in Iceland
F Jonasson et al
751
Eye
secondary glaucomas, though this view remains to be
fully vindicated.14
We have shown in a previous article that PEX is a
common and familial condition in Iceland, probably
genetically inherited.27 The prevalence of OAG
subsuming pseudoexfoliative glaucoma is 5.4% for
65 to 74-year-olds in the present study, 5.3% in the
mid-Norway Eye Study,28 and 5.7% in a Swedish study,29
all populations with a high prevalence of PEX. Like in all
previous studies from Iceland, narrow-angle glaucoma is
rare,1–4 only one case being identified.
Interestingly, we did not come across any cases of
pigment dispersion syndrome. For a definite diagnosis of
OAG in early stages, several visits to an ophthalmologist
over time may be necessary. In a prevalence survey it
may, however, be possible to identify these persons as
GSs for further follow-up. It is of interest in the present
survey that contrary to glaucoma and PEX, there is no
significant age-related increase in the prevalence of GSs.
It is also of interest that PEX, while being a significant
risk factor for GSs is not a significant risk factor for OAG
using the present definition. Analysing, however, those
43 people with a history of OAG and pressure-lowering
treatment, PEX is found to be an important risk factor for
OAG, OR 4.1 (95% CI 2.1–8.1, Po0.001). It is not clear if
this discrepancy is the result of ocular hypertensives
being classified as OAG in the group of those with
history of OAG or if the present definition is less suited
for populations with a high prevalence of PEX or both.
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